GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumos Diagnostics Holdings Ltd (ASX:LDX) » Definitions » Total Payout Ratio

Lumos Diagnostics Holdings (ASX:LDX) Total Payout Ratio : 0.57 (As of Jun. 20, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Lumos Diagnostics Holdings Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

Lumos Diagnostics Holdings's current Total Payout Ratio is 0.57.


Lumos Diagnostics Holdings Total Payout Ratio Historical Data

The historical data trend for Lumos Diagnostics Holdings's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumos Diagnostics Holdings Total Payout Ratio Chart

Lumos Diagnostics Holdings Annual Data
Trend Jun22 Jun23
Total Payout Ratio
0.17 -

Lumos Diagnostics Holdings Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23
Total Payout Ratio Get a 7-Day Free Trial -1.62 0.55 - - 0.78

Competitive Comparison of Lumos Diagnostics Holdings's Total Payout Ratio

For the Diagnostics & Research subindustry, Lumos Diagnostics Holdings's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lumos Diagnostics Holdings's Total Payout Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Lumos Diagnostics Holdings's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where Lumos Diagnostics Holdings's Total Payout Ratio falls into.



Lumos Diagnostics Holdings Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

Lumos Diagnostics Holdings's Total Payout Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (0 + 0 + 0) / -13.367
=0.00

Lumos Diagnostics Holdings's Total Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Total Payout Ratio=- (Repurchase of Stock + Issuance of Stock + Cash Flow for Dividends) / Net Income
=- (-0.527 + 7.996 + 0) / -9.581
=0.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumos Diagnostics Holdings Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of Lumos Diagnostics Holdings's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumos Diagnostics Holdings (ASX:LDX) Business Description

Traded in Other Exchanges
Address
2724 Loker Ave West, Carlsbad, CA, USA, 92010
Lumos Diagnostics Holdings Ltd is engaged in the development, manufacture and distribution of point-of-care diagnostic (POC) tests and associated readers for analysis of POC diagnostic tests. It also directly develops, manufactures and commercializes proprietary, Lumos-branded POC tests that target infectious and inflammatory diseases. It generates maximum revenue from the commercial services and solutions relating to POC diagnostic tests.

Lumos Diagnostics Holdings (ASX:LDX) Headlines

No Headlines